₹2,004 - That's What Analysts Think Dalmia Bharat Limited (NSE:DALBHARAT) Is Worth After These Results

It's been a good week for Dalmia Bharat Limited (NSE:DALBHARAT) shareholders, because the company has just released its latest annual results, and the shares gained 6.2% to ₹1,966. Results look mixed - while revenue fell marginally short of analyst estimates at ₹140b, statutory earnings beat expectations 3.3%, with Dalmia Bharat reporting profits of ₹36.42 per share. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

We've discovered 1 warning sign about Dalmia Bharat. View them for free.
earnings-and-revenue-growth
NSEI:DALBHARAT Earnings and Revenue Growth April 26th 2025

Following the latest results, Dalmia Bharat's 28 analysts are now forecasting revenues of ₹156.3b in 2026. This would be a solid 12% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to soar 56% to ₹56.89. Yet prior to the latest earnings, the analysts had been anticipated revenues of ₹159.2b and earnings per share (EPS) of ₹51.15 in 2026. Although the revenue estimates have not really changed, we can see there's been a nice increase in earnings per share expectations, suggesting that the analysts have become more bullish after the latest result.

View our latest analysis for Dalmia Bharat

The consensus price target rose 5.2% to ₹2,004, suggesting that higher earnings estimates flow through to the stock's valuation as well. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Dalmia Bharat analyst has a price target of ₹2,350 per share, while the most pessimistic values it at ₹1,521. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The analysts are definitely expecting Dalmia Bharat's growth to accelerate, with the forecast 12% annualised growth to the end of 2026 ranking favourably alongside historical growth of 9.8% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 2.3% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Dalmia Bharat is expected to grow much faster than its industry.

Advertisement

The Bottom Line

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Dalmia Bharat following these results. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Dalmia Bharat analysts - going out to 2028, and you can see them free on our platform here.

Before you take the next step you should know about the 1 warning sign for Dalmia Bharat that we have uncovered.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:DALBHARAT

Dalmia Bharat

Manufactures and sells cement and its related products primarily in India.

Proven track record with adequate balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
GIFT logo
Lou_Basenese on Giftify ·

Giftify ($GIFT): A Small-Cap Incentives Platform with More ScaleThan Its Valuation Suggests

Fair Value:US$2.551.6% undervalued
19 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$58016.4% overvalued
29 users have followed this narrative
3 users have commented on this narrative
30 users have liked this narrative
TH
LMT logo
TheBestInvestor on Lockheed Martin ·

Orbit + Aero + Defense

Fair Value:US$673.8823.8% undervalued
15 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
AG
Agricola
STGO logo
Agricola on Steppe Gold ·

A case for Steppe Gold, bear case CAD $4, base case CAD $15, bull case CAD $25

Fair Value:CA$2594.4% undervalued
22 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

PE
Peptide_gcr
BANB logo
Peptide_gcr on Bachem Holding ·

Bachem Holding - The Purest Public Peptide Play?

Fair Value:CHF 249.9972.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ES
CPRT logo
Esteban on Copart ·

CPRT 04-2026

Fair Value:US$23.0343.6% overvalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
LE
GEV logo
lexdrew1 on GE Vernova ·

GE Vernova revenue will grow by 13% with a future PE of 64.7x

Fair Value:US$1.17k2.2% undervalued
19 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3957.5% overvalued
52 users have followed this narrative
3 users have commented on this narrative
43 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.231.8% undervalued
66 users have followed this narrative
2 users have commented on this narrative
23 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$579.5726.7% undervalued
1388 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative